Abstract
Iron oxide nanoparticles provide an alternative to gadolinium based contrast agents for use in magnetic resonance imaging of brain tumors. These nanoparticles have different biologic and imaging properties that provide complementary information about inflammation and subtle defects in the blood-brain barrier that are not seen with gadolinium as well as repeated serial imaging without the readministration of contrast agents. These particles can also be used with dynamic magnetic resonance imaging to measure perfusion properties of brain tumors without the confounding effects of blood brain barrier permeability on the measurements. Cellular labeling using iron oxide nanoparticles may allow for imaging of cellular trafficking in the brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
REFERENCES
Arbab, A.S., Yocum, G.T., Kalish, H., Jordan, E.K., Anderson, S.A., Khakoo, A.Y., Read, E.J., and Frank, J.A. (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217–1223
Arbab, A.S., Rad, A.M., Iskander, A.S., Jafari-Khouzani, K., Brown, S.L., Churchman, J.L., Ding, G., Jiang, Q., Frank, J.A., Soltanian-Zadeh, H., and Peck, D.J. (2007) Magnetically-labeled sensitized splenocytes to identify glioma by MRI: a preliminary study. Magn. Reson. Med. 58:519–526
Bremer, C., Mustafa, M., Bogdanov, A., Jr., Ntziachristos, V., Petrovsky, A., and Weissleder, R. (2003) Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology 226:214–220
Cao, Y., Tsien, C.I., Nagesh, V., Junck, L., Ten Haken, R., Ross, B.D., Chenevert, T.L., and Lawrence, T.S. (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT. Int. J. Radiat. Oncol. Biol. Phys. 64:876–885
Denis, M.C., Mahmood, U., Benoist, C., Mathis, D., and Weissleder, R. (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc. Natl. Acad. Sci. USA 101:12634–12639
Enochs, W.S., Harsh, G., Hochberg, F., and Weissleder, R. (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging 9:228–232
Harisinghani, M.G., Barentsz, J., Hahn, P.F., Deserno, W.M., Tabatabaei, S., van de Kaa, C.H., de la Rosette, J., and Weissleder, R. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348:2491–2499
Hunt, M.A., Bago, A.G., and Neuwelt, E.A. (2005) Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10. AJNR Am. J. Neuroradiol. 26:1084–1088
Jaffer, F.A., and Weissleder, R. (2005) Molecular imaging in the clinical arena. JAMA 293:855–862
Jung, C.W., and Jacobs, P. (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13:661–674
Keller, T.M., Michel, S.C.A., Frohlich, J., Fink, D., Caduff, R., Marincek, B., and Kubik-Huch, R.A. (2004) USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur. Radiol. 14:937–944
Kircher, M. F., Mahmood, U., King, R. S., Weissleder, R., and Josephson, L. (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63:8122–8125
Knauth, M., Aras, N., Wirtz, C.R., Dorfler, A., Engelhorn, T., and Sartor, K. (1999) Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am. J. Neuroradiol. 20:1547–1553
Knauth, M., Egelhof, T., Roth, S.U., Wirtz, C.R., and Sartor, K. (2001a) Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. AJNR Am. J. Neuroradiol. 22:99–102
Knauth, M., Wirtz, C.R., Aras, N., and Sartor, K. (2001b) Low-field interventional MRI in neurosurgery: finding the right dose of contrast medium. Neuroradiology 43:254–258
Landry, R., Jacobs, P.M., Davis, R., Shenouda, M., and Bolton, W.K. (2005) Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients. Am. J. Nephrol. 25:400–410
Moore, A., Marecos, E., Bogdanov, A., Jr., and Weissleder, R. (2000) Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568–574
Muldoon, L.L., Sandor, M., Pinkston, K.E., and Neuwelt, E.A. (2005) Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57:785–796
Murillo, T.P., Sandquist, C., Jacobs, P.M., Nesbit, G., Manninger, S., and Neuwelt, E.A. (2005) Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent. Therapy 2:871–882
Neuwelt, E.A., Weissleder, R., Nilaver, G., Kroll, R.A., Roman-Goldstein, S., Szumowski, J., Pagel, M.A., Jones, R. S., Remsen, L.G., McCormick, C.I., Shannon, E.M., and Muldoon, L.L. (1994) Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34:777–784
Neuwelt, E.A., Varallyay, P., Bago, A.G., Muldoon, L.L., Nesbit, G., and Nixon, R. (2004) Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol. Appl. Neurobiol. 30:456–471
Neuwelt, E.A., Varallyay, C.G., Manninger, S., Solymosi, D., Haluska, M., Hunt, M.A., Nesbit, G., Stevens, A., Jerosch-Herold, M., Jacobs, P.M., and Hoffman, J.M. (2007) The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. Neurosurgery 60:601–611; discussion 611–602
Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., and Corot, C. (2004) Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 39:56–63
Remsen, L.G., McCormick, C.I., Roman-Goldstein, S., Nilaver, G., Weissleder, R., Bogdanov, A., Hellstrom, I., Kroll, R.A., and Neuwelt, E.A. (1996) MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am. J. Neuroradiol. 17:411–418
Taschner, C.A., Wetzel, S.G., Tolnay, M., Froehlich, J., Merlo, A., and Radue, E.W. (2005) Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR Am. J. Roentgenol. 185:1477–1486
Varallyay, P., Nesbit, G., Muldoon, L.L., Nixon, R.R., Delashaw, J., Cohen, J.I., Petrillo, A., Rink, D., and Neuwelt, E.A. (2002) Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am. J. Neuroradiol. 23:510–519
Wirtz, C.R., Knauth, M., Staubert, A., Bonsanto, M.M., Sartor, K., Kunze, S., and Tronnier, V.M. (2000) Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 46:1112–1120; discussion 1120–1112
Zimmer, C., Wright, S.C., Jr., Engelhardt, R.T., Johnson, G.A., Kramm, C., Breakefield, X.O., and Weissleder, R. (1997) Tumor cell endocytosis imaging facilitates delineation of the glioma–brain interface. Exp. Neurol. 143:61–69
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Hunt, M.A., Neuwelt, E.A. (2011). Magnetic Resonance Imaging of Brain Tumors Using Iron Oxide Nanoparticles. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8665-5_23
Download citation
DOI: https://doi.org/10.1007/978-90-481-8665-5_23
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8664-8
Online ISBN: 978-90-481-8665-5
eBook Packages: MedicineMedicine (R0)